Sherri Tenpenny's notes on Hep. B and Molecular Mimicry

[Mzjelybely]

Hep. B and Molecular Mimicry

Hep. B

-A DNA virus
- Symptoms begin with nausea, vomiting, fever, malaise, icteric phase in 3-10 days.
-Treatment is symptomatic
-Recovery in 4-8 weeks

Hep. B is spread by blood and blood contaminated products
***70% of all infections occur in high-risk groups***
What are the high risk groups? Homeless population, drug-users (sharing IV's), prostitutes, alcoholics, and homosexuals

***Note: NOT newborn babies***

In hep. b cases:
50% develop no symptoms after exposure; life-long immunity
30% develop flu like symptoms only; life-long immunity
20% develop symptoms that lead to a diagnosis of hep. B

OF THAT 20%:
-95% fully recover
-<5% become chronic carriers
-75% live with asymptomatic infection
-25% develop liver disease 10-30 years after infection

-Merck Manual, Sec. 4, Chapt. 42.
-Hyams, K.C (1995) Risks of chronicity following acute hepatitis B virus infection: A review. Chn. Infect. Dis. 20, 992-1000

"Any presumed risk of adverse events possibly associated with hep. B must be balanced against the expected risk of acute and chronic liver disease."
-MMWR 40(RR-13) p. 10

1.25% become chronic carriers and even fewer develop liver disease. Isn't it possible that people in high risk groups are doing things to their bodies for 10-30 years that can have some effect on their liver?

"There is no doubt that the recombinant Hepatitis B virus vaccine has the ability to trigger autoimmunity."
-Cohen AD. Vaccine-induced autoimmunity. Journal of Autoimmunity. Dec. 1996; 9(6):699-703. PMID: 9115571

MOLECULAR MIMICRY

"Hep. B antibody level >10 mIU/mL = the standard for demonstrating post vaccination protection against hep. b."
-CDC Sensitivity of the test for antibody to hepatitis B surface antigen, MMWR 1987; 36:354-60, 366

Energix B vaccination study
@7 months post vaccination, Adults still had 2204 mIU/mL
@4 months post vaccination, infants still had 2942 mIU/mL

WHEN ALL THEY NEED IS 10. WHAT ARE ALL THOSE OTHER ANTIBODIES DOING IN THERE?

"Even though data regarding the relation between vaccination and autoimmune disease is conflicting, some autoimmune phenomena are clearly related to immunization.

"Molecular Mimicry: a structural similarity between a virus and a self-antigen. This similarity may trigger an autoimmune reaction."
Shoenfeld, Y. Vaccination and autoimmunity - 'vaccinosis': a dangerous liason? Journal of Autoimmunity 2000 Feb; 14(1): 1-10

In laymans terms, this means that all the antibodies in there have nothing to do and there are thousands of them. What antibodies are designed to do is recognize the amino acid sequence of a disease cell and kill it. With all those antibodies running around with nothing to do, they find a similar sequence on the surface of an organ. That is why we see so many more cases of diabetes, kawasaki's disease, children's arthritis, epilepsy and more.

AND THAT IS JUST ONE VACCINE. KIDS GET 96 IMMUNIZATIONS BEFORE KINDERGARTEN NOW.

BACK TO HEP. B

"This document provides the rationale for a comprehensive strategy to eliminate transmission of hep. B virus in the US. This prevention strategy includes making hep. B a part of the routine vaccination schedule for all infants.
...In most developing countries, the first dose of vaccine is administered to all infants soon after birth to prevent perinatal infections; pregnant women are not screened for HBsAg and HBIG is not used.
...The feasibility and effectiveness of incorporating this approach into the strategy for the US must be evaluated."

MMWR 40(RR-13); 1-19

Translation: We do it in third world countries where hep. B is endemic so we are going to do it here. We are not going to test to see if the mother has hep. B virus or immune globulin to see if the infant is at risk before giving the injection."

A manufacturer's representative was asked in a 197 Illinois Board of Health hearing to show evidence that the hep. B vaccine is safe for a 1 day old baby. His response:

"We have none. Our studies were done on 5 and 10 year olds."
-The Congressional Quarterly August 25, 2000, pg. 647

30-50% of all people vaccinated against hep. B lose antibodies within 7 years.
60% will lose all antibodies in 12 years
MMWR 46(RR-18); 1-42 Deember, 26, 1997

SO, by the time our kids grow up to be IV-sharing, drug abusing prostitutes, they won't be immune anymore.

WHY ARE WE GIVING THIS VACCINE TO NEWBORN BABIES AGAIN?


From insidevaccines.com/wordpress:

What are the Risks with the Hepatitis B Vaccine?

The Vaccine Injury Compensation Program (VICP) established a Hepatitis B-Neurological Demyelinating Omnibus Proceeding.
Here’s one compensated case for Transverse Myelitis:
http://www.ccandh.com/decisions/stevens_2-24-06.pdf
A compensated case for Multiple Sclerosis:
http://www.ccandh.com/decisions/werderitsh_5-26-06.pdf
A compensated case for Guillain-Barré Syndrome:
http://www.ccandh.com/decisions/gilbert_3-30-06.pdf
From the Recombivax (Merck) package insert:
http://www.merck.com/product/usa/pi_circul…combivax_pi.pdf
Hypersensitivity
Anaphylaxis and symptoms of immediate hypersensitivity reactions including rash, pruritus, urticaria, edema, angioedema, dyspnea, chest discomfort, bronchial spasm, palpitation, or symptoms consistent with a hypotensive episode have been reported within the first few hours after vaccination.
An apparent hypersensitivity syndrome (serum-sickness-like) of delayed onset has been reported days to weeks after vaccination, including: arthralgia/arthritis (usually transient), fever, and dermatologic reactions such as urticaria, erythema multiforme, ecchymoses and erythema nodosum (see WARNINGS and
PRECAUTIONS).
Digestive System
Elevation of liver enzymes; constipation
Nervous System
Guillain-Barré Syndrome; multiple sclerosis; exacerbation of multiple sclerosis; myelitis including transverse myelitis; seizure; febrile seizure; peripheral neuropathy including Bell’s Palsy; radiculopathy; herpes zoster; migraine; muscle weakness; hypesthesia; encephalitis
Integumentary System
Stevens-Johnson Syndrome; alopecia; petechiae; eczema
Musculoskeletal System
Arthritis
Pain in extremity
Hematologic
Increased erythrocyte sedimentation rate; thrombocytopenia
Immune System
Systemic lupus erythematosus (SLE); lupus-like syndrome; vasculitis; polyarteritis nodosa
Psychiatric/Behavioral
Irritability; agitation; somnolence
Special Senses
Optic neuritis; tinnitus; conjunctivitis; visual disturbances
Cardiovascular System
Syncope; tachycardia.
_________________________________________________________________
http://www.neurology.org/cgi/content/abstract/63/5/838
Conclusions: These findings are consistent with the hypothesis that immunization with the recombinant hepatitis B vaccine is associated with an increased risk of MS, and challenge the idea that the relation between hepatitis B vaccination and risk of MS is well understood.
(fulltext here)
http://www.mdconsult.com/das/article/body/…01704000838.pdf